Mean Pulmonary Arterial Pressure Decreases with Exposure Time in the Tibet Plateau |Biomedgrid
Journal: American Journal of Biomedical Science & Research (Vol.12, No. 5)Publication Date: 2021-04-27
Authors : Qian Chen; Delong Duo; Yingjun Yan; Qirong Yan; Zhengxing Ma; Qian Li; Yafeng Wang;
Page : 479-486
Keywords : High Altitude; Pulmonary Arterial Hypertension; Altitude Acclimatization; Cellular; Oxygen;
Abstract
Hypoxic pulmonary hypertension (HPH) is a severe and progressive disease characterized by pulmonary vascular remodeling, increased pulmonary vascular resistance, right ventricular hypertrophy and, if not reversed, death. We maintained laboratory rats at two altitudes (2261 and 4300 meters, 75.2% O2 and 58.5% O2) on the Qinghai Tibetan Plateau and measured the changes in mean pulmonary pressure (mPAP) over two months. In the first month mPAP increased by 30 mmHg, while in the second month mPAP returned to normal. We hypothesized that the secondary decrease in mean pulmonary artery pressure was associated with the production of vasodilators, decreased cardiac output, and genes involved in adaptation to higher altitudes, including EGLN1, PPARα and HIF-2α.
Other Latest Articles
- Multi Drug Resistant Tuberculosis in Bhutan: A Look into The Line Probe Assay Results |Biomedgrid
- Heart Rate Variability and Perceptual Well-Being in Triathlon – A Case Report |Biomedgrid
- A Novel HBA1 Gene Polymorphism in Vietnamese Population: C.172G>A (P. Gly58Ser) |Biomedgrid
- Ageing and Increasing Doses are Factors Related to Delays for Adults with Haemophilia to Seek Prophylactic Clotting Factors |Biomedgrid
- Hiccups in COVID-19: A rare complaint with many possible causes |Biomedgrid
Last modified: 2023-08-17 21:59:28